REDUCTION IN VULNERABILITY TO VENTRICULAR-FIBRILLATION BY BROMOCRIPTINE, A DOPAMINE AGONIST

被引:27
作者
FALK, RH [1 ]
DESILVA, RD [1 ]
LOWN, B [1 ]
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,CARDIOVASC RES LABS,BOSTON,MA 02115
关键词
D O I
10.1093/cvr/15.3.175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:175 / 180
页数:6
相关论文
共 36 条
[21]  
PARKES D, 1979, NEW ENGL J MED, V301, P873
[22]   MUSCARINIC EFFECTS OF VAGO-SYMPATHETIC TRUNK STIMULATION ON REPETITIVE EXTRASYSTOLE (RE) THRESHOLD [J].
RABINOWITZ, SH ;
VERRIER, RL ;
LOWN, B .
CIRCULATION, 1976, 53 (04) :622-627
[23]   CENTRAL NEUROCHEMICAL FACTORS RELATED TO SEROTONIN METABOLISM AND CARDIAC VENTRICULAR VULNERABILITY FOR REPETITIVE ELECTRICAL-ACTIVITY [J].
RABINOWITZ, SH ;
LOWN, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (03) :516-522
[24]  
REYNTJENS A, 1979, POSTGRAD MED J S1, P50
[25]  
ROLLAND R, 1978, ACTA ENDOCR-COP S, V216, P119
[26]   EFFECTS OF CLONIDINE ON VULNERABILITY TO FIBRILLATION IN NORMAL AND ISCHEMIC CANINE VENTRICLE [J].
ROTENBERG, FA ;
VERRIER, RL ;
LOWN, B ;
SOLE, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (01) :71-79
[27]  
SCHOLTYSIK G, 1978, BR J PHARM, V62, P379
[28]  
SCHWARTZ PJ, 1976, AM J CARDIOL, V37, P1036
[29]  
STUMPE, 1977, LANCET, V2, P211
[30]  
THORNER MO, 1975, LANCET, V1, P662